Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-04
DOI
10.1038/s41598-020-60212-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Interfering with endolysosomal trafficking enhances release of bioactive exosomes
- (2019) Francisco G. Ortega et al. Nanomedicine-Nanotechnology Biology and Medicine
- The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
- (2019) Huan Dong et al. Cancer Medicine
- Advances in Hypoxia-Inducible Factor Biology
- (2018) Hani Choudhry et al. Cell Metabolism
- Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer
- (2018) Fangfang Fu et al. Translational Oncology
- The Dual Role of MicroRNAs in Colorectal Cancer Progression
- (2018) Lei Ding et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
- (2018) Mayte Delgado-Ureña et al. Journal of Translational Medicine
- Role of hypoxia-induced exosomes in tumor biology
- (2018) Chuchu Shao et al. Molecular Cancer
- Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
- (2017) Mitsuo Tsukamoto et al. ONCOLOGY
- Colorectal cancer screening: An updated review of the available options
- (2017) Iyad A Issa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients
- (2017) Surajit Pathak et al. Oncotarget
- Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
- (2017) Linda Zuurbier et al. Oncotarget
- KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients
- (2017) De-cong Sun et al. Scientific Reports
- Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
- (2017) Jialin Song et al. Frontiers in Immunology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Le statut KRAS n’influence pas l’efficacité de l’oxaliplatine ou de l’irinotécan, en association au bévacizumab, dans le traitement de première ligne du cancer colorectal métastatique
- (2016) Mathilde Cabart et al. BULLETIN DU CANCER
- Extracellular miRNA: A Collision of Two Paradigms
- (2016) Andrey Turchinovich et al. TRENDS IN BIOCHEMICAL SCIENCES
- KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes
- (2016) Andrew J. McKenzie et al. Cell Reports
- Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer
- (2015) Matthew G. Krebs et al. Clinical Colorectal Cancer
- Unknown
- (2015) Jennifer Hardingham et al. MOLECULAR MEDICINE
- G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
- (2015) Ondrej Fiala et al. TUMOR BIOLOGY
- Absolute quantification of cell-free microRNAs in cancer patients
- (2015) Manuela Ferracin et al. Oncotarget
- miRNA in situ hybridization in circulating tumor cells - MishCTC
- (2015) Francisco G. Ortega et al. Scientific Reports
- KRAS-dependent sorting of miRNA to exosomes
- (2015) Diana J Cha et al. eLife
- MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2014) Xin Yang et al. PLoS One
- Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
- (2014) Hiroko Ogata-Kawata et al. PLoS One
- MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
- (2014) Verena Stiegelbauer WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting mTOR network in colorectal cancer therapy
- (2014) Xiao-Wen Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Predictive Biomarkers for Bevacizumab: Are We There Yet?
- (2013) D. Maru et al. CLINICAL CANCER RESEARCH
- Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab
- (2013) Javier Sastre et al. Clinical Colorectal Cancer
- Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
- (2013) H. I. Hurwitz et al. ONCOLOGIST
- Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome-Wide Profiling and Validation Study
- (2012) María Dolores Giráldez et al. Clinical Gastroenterology and Hepatology
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating Tumor Cells in Colorectal Cancer: Past, Present, and Future Challenges
- (2010) Benjamin P. Negin et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes
- (2010) Jung Eun Park et al. MOLECULAR & CELLULAR PROTEOMICS
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started